Table 1.
Characteristics of patients in relation to heart failure classification
| DHF | NHF | |
|---|---|---|
| Registered HF in the NRP (n) | 637 | 121 |
| Age, years | 75.7 | 69.9 |
| Male (%) | 60.4 | 43.8 |
| IHD (%) | 55.9 | 29.8 |
| BMI (kg/m2) | 25.5 | 28.2 |
| Hypertension (%) | 45.5 | 53.7 |
| Diabetes (%) | 18.7 | 16.5 |
| COPD (%) | 15.5 | 9.9 |
| Atrial fibrillation (%) | 47.6 | 19.0 |
| ECG performed (%) | 97.8 | 91.7 |
| Sinus rhythm (%) | 56.0 | 82.0 |
| Atrial fibrillation (%) | 39.2 | 16.2 |
| Hypertrophy (%) | 20.4 | 10.8 |
| Ischemia (%) | 58.4 | 29.7 |
| Echo performed (%) | 95.1 | 77.7 |
| LVEF%; median | 35 | 60 |
| Aortic stenosis | ||
| Mild (%) | 1.0 | 0 |
| Moderate (%) | 1.7 | 0 |
| Severe (%) | 5.3 | 0 |
| Mitral valve regurgitation | ||
| Mild (%) | 36.8 | 15.4 |
| Moderate (%) | 15.2 | 0 |
| Severe (%) | 4.2 | 0 |
| Tricuspid regurgitation (≥40 mmHg) (%) | 20.4 | 0 |
| Chest X-ray performed (%) | 79.7 | 62.8 |
| Pulmonary congestion (%) | 43.7 | 0 |
| Creatinine (umol/L); median | 106 | 106 |
| Follow-up in HFC/OPC (%) | 56.2 | 1.7 |
| Medical treatment | ||
| ACE-inhibitor/AII-antagonist (%) | 78.6 | 33.9 |
| Beta-blocker (%) | 67.5 | 28.9 |
| Spironolactone (%) | 32.7 | 5.8 |
| Readmission (12 months)% | 54.6 | 37.2 |
| H F (%) | 13.8 | 0 |
| AMI (%) | 3.5 | 0 |
| Angina pectoris (%) | 5.0 | 3.3 |
| Stroke (%) | 2.7 | 1.7 |
| Atrial fibrillation (%) | 2.7 | 2.5 |
Abbreviations: ACE, angiotensin-converting enzyme; AMI, acute myocardial infarction; BMI, body mass index; COPD, chronic obstructive pulmonary disease; IHD, ischemic heart disease; HF, heart failure; HFC, heart failure clinic; LVEF, left ventricular ejection fraction; OPC, outpatient clinic.